> UK refusing to pay for a drug if it doesn't meet cost-effectiveness.. though I'm not sure how exactly that winds up affecting which drugs are available and wh

> UK refusing to pay for a drug if it doesn't meet cost-effectiveness.. though I'm not sure how exactly that winds up affecting which drugs are available and which aren't. It means the supplier has a choice: meet the cost effectiveness model's price, or earn almost no money in that market. It's a powerful tool and run quite transparently. Look up the National Institute for Clinical Excellence. There is occasionally some political blowback that distorts the purity of it, but generally it works pretty well.